EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery

Eric K Marecki iD, Kwang W Oh iD, Paul R Knight iD, Bruce A Davidson iD

Biomicrofluidics · 01.09.2024 · 18 (5)

DOI: 10.1063/5.0201465 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomicrofluidics, online erschienen am 17.09.2024. Verfasst von Eric K Marecki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The State University of New York at Buffalo, Buffalo, New York 14203, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles can be used for drug delivery and consist of many sizes and chemical compositions. They can accommodate a diverse population of drugs and can be made to target specific areas of the body. Fabrication methods generally follow either top-down or bottom-up manufacturing techniques, which have differing production controls, which determine nanoparticle characteristics including but not limited to size and encapsulation efficiency. Functionalizing these nanoparticles is done to add drugs, prevent aggregation, add positive charge, add targeting, etc. As the nanoparticles reach the target cells, cellular uptake occurs, drug is released, and the nanoparticle is broken down. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles have often been used for drug delivery applications as they have shown minimal toxicity, which has helped with US FDA approval. This review breaks down PLGA nanoparticle fabrication, functionalization, and biological considerations.

Autor:innen und Institutionen

  • Department of Anesthesiology, The State University of New York at Buffalo, Buffalo, New York 14203, USA.

ORCID-Profile: Eric K Marecki, Kwang W Oh, Paul R Knight, Bruce A Davidson

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Marecki, E. K., Oh, K. W., Knight, P. R., & Davidson, B. A. (2024). Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery. Biomicrofluidics, 18(5). https://doi.org/10.1063/5.0201465

Vancouver

Marecki EK, Oh KW, Knight PR, Davidson BA. Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery. Biomicrofluidics. 2024;18(5). doi:10.1063/5.0201465

BibTeX
@article{Marecki2024,
  author = {Marecki, Eric K and Oh, Kwang W and Knight, Paul R and Davidson, Bruce A},
  title = {Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery},
  journal = {Biomicrofluidics},
  year = {2024},
  volume = {18},
  number = {5},
  doi = {10.1063/5.0201465}
}
Kostenlos starten →